Investors

Corporate Profile

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease.

The company’s Orbital Atherectomy Systems treat calcified and fibrotic plaque in arterial vessels throughout the leg and heart in a few minutes of treatment time, and address many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives.

The U.S. FDA granted 510(k) clearance for the use of the Diamondback Orbital ... More >>

Stock Quote

CSII (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$30.22
Change (%) Stock is Down 0.12 (0.40%)
Volume204,788
Data as of 07/27/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

Upcoming Events

More >>
There are currently no events scheduled.

Recent News

More >>
07/15/15
Cardiovascular Systems to Webcast Fiscal 2015 Fourth-Quarter Earnings Conference Call Wednesday, August 5
Live Webcast at 3:45 p.m. CT (4:45 p.m. ET) ST. PAUL, Minn.--(BUSINESS WIRE)--Jul. 15, 2015-- Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a live webcast of its fiscal 2015 fourth-quarter conference call on Wednesday, August 5, 2015, at 3:45 p.m. CT (4:45 p.m. ET). David Martin, President and Chief Executive Officer, and Larry Betterley, Chief Financial Officer, will discuss the company’s results for its fiscal fourth quarter en... 
07/13/15
Cardiovascular Systems Completes Coast Study Enrollment
International Coronary Trial to Assess the Safety and Efficacy of New Coronary Micro Crown ST. PAUL, Minn.--(BUSINESS WIRE)--Jul. 13, 2015-- Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), announced that it has completed enrollment for its Coronary Orbital Atherectomy System Trial (COAST) study. Taking place in both Japan and the United States, the study is designed to assess the safety and efficacy, as well as economic outcomes, of CSI’s n... 
07/06/15
FDA Clears Next-Generation Guide Wire for Cardiovascular Systems' Peripheral Orbital Atherectomy Systems
ViperWire Advance Peripheral Guide Wire with Flex Tip Offers Greater Flexibility and Navigation; Improves Systems’ Ease-of-Use When Treating Calcified Lesions in Torturous Arterial Anatomy ST. PAUL, Minn.--(BUSINESS WIRE)--Jul. 6, 2015-- Cardiovascular Systems, Inc. (NASDAQ:CSII) (CSI), today announced that it has received FDA clearance for its new ViperWire Advance® Peripheral Guide Wire with Flex Tip for their Peripheral Orbital Atherectomy ... 
06/02/15
Cardiovascular Systems to Present at William Blair & Company's 35th Annual Growth Stock Conference
ST. PAUL, Minn.--(BUSINESS WIRE)--Jun. 2, 2015-- On Thursday, June 11, 2015, Cardiovascular Systems’ (NASDAQ: CSII) President and Chief Executive Officer, David L. Martin, will present at William Blair & Company’s 35th Annual Growth Stock Conference at 9:40 a.m. Eastern Time. You may access the live audio webcast and presentation materials in the Investors section at: www.csi360.com. Presentation materials also will be archived on CSI’... 

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.